Crestwood Advisors Group’s Compugen CGEN Stock Holding History

Crestwood Advisors Group’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,720	Closed	-$11.3K	–	262
2022 Q4	$11.3K	Hold	15,720	–	–	﹤0.01%	264
2022 Q3	$10K	Hold	15,720	–	–	﹤0.01%	269
2022 Q2	$29K	Hold	15,720	–	–	﹤0.01%	264
2022 Q1	$51K	Sell	15,720 -4,250	-21%	-$14.4K	﹤0.01%	282
2021 Q4	$86K	Hold	19,970	–	–	﹤0.01%	292
2021 Q3	$119K	Sell	19,970 -750	-4%	-$5.02K	﹤0.01%	264
2021 Q2	$172K	Buy	20,720 +750	+4%	+$6.09K	0.01%	264
2021 Q1	$172K	Buy	19,970 +4,150	+26%	+$46K	0.01%	255
2020 Q4	$192K	Buy	15,820 +850	+6%	+$11.7K	0.01%	259
2020 Q3	$243K	Buy	14,970 +2,000	+15%	+$32.8K	0.01%	213
2020 Q2	$195K	Buy	+12,970	New	+$175K	0.01%	225

Other funds holding CGEN

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ACM

Antonetti Capital Management Naples, Florida $64M AUM 3.84% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Crestwood Advisors Group's CGEN Position: Q1 2023 in Review

Crestwood Advisors Group sold out of Compugen (CGEN) in Q1 2023, closing a stake of 15,720 shares — an estimated $11.3K sold.

Crestwood Advisors Group first reported a position in CGEN in Q2 2020 and held it in 11 quarters. The position peaked at $243K in Q3 2020. 68 funds tracked by Wall St. Rank hold CGEN as of Q1 2023.

Crestwood Advisors Group reported no remaining Compugen position as of Q1 2023 after selling out during the quarter.
Crestwood Advisors Group sold 15,720 Compugen shares in Q1 2023, an estimated $11.3K.
Crestwood Advisors Group first reported a position in Compugen in Q2 2020 and held it in 11 quarters.
Crestwood Advisors Group's Compugen position peaked at $243K in Q3 2020.
68 funds tracked by Wall St. Rank held Compugen as of Q1 2023.

Based on Crestwood Advisors Group's 13F filing for Q1 2023, filed 12 May 2023.